Dr. Desai is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1825 4th Street
San Francisco, CA 94158
Education & Training
University at BuffaloResidency, Internal Medicine, 2011 - 2014
Kempegowda Institute of Medical ScienceClass of 2009
Certifications & Licensure
CA State Medical License 2014 - 2026
IL State Medical License 2016 - 2020
NY State Medical License 2016 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 308 citationsKidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.Robert J Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine
Journal of the National Comprehensive Cancer Network. 2022-01-01 - 9 citationsAPOBEC Mutational Signature and Tumor Mutational Burden as Predictors of Clinical Outcomes and Treatment Response in Patients With Advanced Urothelial Cancer.Divya Natesan, Li Zhang, Henry J Martell, Tanya Jindal, Patrick Devine
Frontiers in Oncology. 2022-01-01 - 21 citationsTERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.Ivan de Kouchkovsky, Li Zhang, Errol J. Philip, Francis Wright, Daniel M Kim
Journal for Immunotherapy of Cancer. 2021-05-01
Press Mentions
Upfront TKI for Bone-Predominant RCC Tops Single-Agent ImmunotherapyNovember 12th, 2024- Higher Risk of Kidney Cancer Recurrence After Ablative TherapyNovember 10th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
